Low-dose lipopolysaccharide (LPS) inhibits aggressive and augments depressive behaviours in a chronic mild stress model in mice

Journal of Neuroinflammation

Volumn 13, Issue 1, 2016, Pages

  Couch, Yvonne ^a   Trofimov, Alexander ^b,c,d   Markova, Natalyia ^c,d   Nikolenko, Vladimir ^e   Steinbusch, Harry W ^c   Chekhonin, Vladimir ^f   Schroeter, Careen ^g   Lesch, Klaus Peter ^b,c   Anthony, Daniel C ^a   Strekalova, Tatyana ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d INSTITUTE OF PHYSIOLOGICALLY ACTIVE COMPOUNDS   (Russian Federation)

^e I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^f Department of Basic and Applied Neurobiology   (Russian Federation)

^g MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

5 HT; Aggressive behaviour; Chronic stress; Cytokines; LPS; SERT

Indexed keywords

CORTICOSTERONE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; SEROTONIN 2A RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

5 HT2A GENE; AGGRESSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; CHRONIC STRESS; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; GENE EXPRESSION; HELPLESSNESS; IL 1BETA GENE; IMPULSIVENESS; MALE; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; RAT; TNFALPHA GENE; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; CHRONIC DISEASE; DISEASE MODEL; DRUG EFFECTS; MENTAL STRESS; METABOLISM; PHYSIOLOGY; PSYCHOLOGY; RANDOMIZATION; WISTAR RAT;

AGGRESSION; ANIMALS; CHRONIC DISEASE; DEPRESSION; DISEASE MODELS, ANIMAL; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; RANDOM ALLOCATION; RATS, WISTAR; STRESS, PSYCHOLOGICAL;

EID: 84968807613     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/s12974-016-0572-0     Document Type: Article

References (77)

1. Anthony DC, Pitossi FJ. Special issue commentary: the changing face of inflammation in the brain. Mol Cell Neurosci. 2013;53:1-5.
2. Pomytkin IA et al. Endotoxaemia resulting from decreased serotonin transporter (5-HTT) function: a reciprocal risk factor for depression and insulin resistance? Behav Brain Res. 2015;276:111-7.
3. Raison CL et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry. 2013;70(1):31-41.
4. Dantzer R. Cytokine, sickness behavior, and depression. Immunol Allergy Clin North Am. 2009;29(2):247-64.
5. Avitsur R et al. Social experience alters the response to social stress in mice. Brain Behav Immun. 2003;17(6):426-37.
6. Perugi G et al. Mixed features in patients with a major depressive episode: the BRIDGE-II-MIX study. J Clin Psychiatry. 2015;76(3):e351-8.
7. Keilp JG et al. Aggressiveness, not impulsiveness or hostility, distinguishes suicide attempters with major depression. Psychol Med. 2006;36(12):1779-88.
8. Coccaro EF, Lee R, Coussons-Read M. Elevated plasma inflammatory markers in individuals with intermittent explosive disorder and correlation with aggression in humans. JAMA Psychiatry. 2014;71(2):158-65.
9. Munhoz CD et al. Chronic unpredictable stress exacerbates lipopolysaccharide-induced activation of nuclear factor-kappaB in the frontal cortex and hippocampus via glucocorticoid secretion. J Neurosci. 2006;26(14):3813-20.
10. Kudryavtseva NN et al. Repeated positive fighting experience in male inbred mice. Nat Protoc. 2014;9(11):2705-17.
11. Honma T et al. Increased systemic inflammatory interleukin-1ss and interleukin-6 during agitation as predictors of Alzheimer's disease. Int J Geriatr Psychiatry. 2013;28(3):233-41.
12. Suarez EC, Lewis JG, Kuhn C. The relation of aggression, hostility, and anger to lipopolysaccharide-stimulated tumor necrosis factor (TNF)-alpha by blood monocytes from normal men. Brain Behav Immun. 2002;16(6):675-84.
13. Coccaro EF. Association of C-reactive protein elevation with trait aggression and hostility in personality disordered subjects: a pilot study. J Psychiatr Res. 2006;40(5):460-5.
14. Zalcman SS, Siegel A. The neurobiology of aggression and rage: role of cytokines. Brain Behav Immun. 2006;20(6):507-14.
15. Barnum CJ et al. Psychological stress in adolescent and adult mice increases neuroinflammation and attenuates the response to LPS challenge. J Neuroinflammation. 2012;9:9.
16. Mommersteeg PM et al. Hostility is related to clusters of T-cell cytokines and chemokines in healthy men. Psychoneuroendocrinology. 2008;33(8):1041-50.
17. Kraus MR et al. Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy. J Clin Psychiatry. 2003;64(6):708-14.
18. McHutchison JG et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med. 1998;339(21):1485-92.
19. Petitto JM et al. Association of genetic differences in social behavior and cellular immune responsiveness: effects of social experience. Brain Behav Immun. 1994;8(2):111-22.
20. Patel A, Siegel A, Zalcman SS. Lack of aggression and anxiolytic-like behavior in TNF receptor (TNF-R1 and TNF-R2) deficient mice. Brain Behav Immun. 2010;24(8):1276-80.
21. Black PH. Stress and the inflammatory response: a review of neurogenic inflammation. Brain Behav Immun. 2002;16(6):622-53.
22. Elenkov IJ, Chrousos GP. Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease. Trends Endocrinol Metab. 1999;10(9):359-68.
23. Pacak K et al. Heterogeneous neurochemical responses to different stressors: a test of Selye's doctrine of nonspecificity. Am J Physiol. 1998;275(4 Pt 2):R1247-55.
24. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27(1):24-31.
25. Dantzer R et al. Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology. 2011;36(3):426-36.
26. Beckham JC et al. Depression and level of functioning in patients with rheumatoid arthritis. Can J Psychiatry. 1992;37(8):539-43.
27. Roehrs T et al. Nocturnal sleep, daytime sleepiness and fatigue in fibromyalgia patients compared to rheumatoid arthritis patients and healthy controls: a preliminary study. Sleep Med. 2013;14(1):109-15.
28. Goshen I et al. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry. 2008;13(7):717-28.
29. Couch Y et al. Microglial activation, increased TNF and SERT expression in the prefrontal cortex define stress-altered behaviour in mice susceptible to anhedonia. Brain Behav Immun. 2013;29:136-46.
30. Leonard BE. The HPA and immune axes in stress: the involvement of the serotonergic system. Eur Psychiatry. 2005;20 Suppl 3:S302-6.
31. Homberg JR, Lesch KP. Looking on the bright side of serotonin transporter gene variation. Biol Psychiatry. 2011;69(6):513-9.
32. Alesci S et al. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab. 2005;90(5):2522-30.
33. Levine J et al. Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology. 1999;40(4):171-6.
34. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA. 1992;267(9):1244-52.
35. Couch Y et al. A model of post-infection fatigue is associated with increased TNF and 5-HT2A receptor expression in mice. PLoS One. 2015;10(7):e0130643.
36. Costa-Nunes J et al. Altered emotionality, hippocampus-dependent performance and expression of NMDA receptor subunit mRNAs in chronically stressed mice. Stress. 2014;17(1):108-16.
37. Elgarf AS et al. Lipopolysaccharide repeated challenge followed by chronic mild stress protocol introduces a combined model of depression in rats: reversibility by imipramine and pentoxifylline. Pharmacol Biochem Behav. 2014;126:152-62.
38. Deak T et al. Validation of a novel social investigation task that may dissociate social motivation from exploratory activity. Behav Brain Res. 2009;199(2):326-33.
39. Gasparotto OC, Carobrez SG, Bohus BG. Effects of LPS on the behavioural stress response of genetically selected aggressive and nonaggressive wild house mice. Behav Brain Res. 2007;183(1):52-9.
40. Raetzsch CF et al. Lipopolysaccharide inhibition of glucose production through the Toll-like receptor-4, myeloid differentiation factor 88, and nuclear factor kappa b pathway. Hepatology. 2009;50(2):592-600.
41. Strekalova T et al. Update in the methodology of the chronic stress paradigm: internal control matters. Behav Brain Funct. 2011;7:9.
42. Cline BH et al. Lasting downregulation of the lipid peroxidation enzymes in the prefrontal cortex of mice susceptible to stress-induced anhedonia. Behav Brain Res. 2015;276:118-29.
43. Strekalova T et al. Tlr4 upregulation in the brain accompanies depression- and anxiety-like behaviors induced by a high-cholesterol diet. Brain Behav Immun. 2015;48:42-7.
44. Strekalova T et al. Stress-induced anhedonia in mice is associated with deficits in forced swimming and exploration. Neuropsychopharmacology. 2004;29(11):2007-17.
45. Pellis SM, McKenna M. What do rats find rewarding in play fighting? An analysis using drug-induced non-playful partners. Behav Brain Res. 1995;68(1):65-73.
46. Strekalova T, Steinbusch HW. Measuring behavior in mice with chronic stress depression paradigm. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:348-361. doi: 10.1016/j.pnpbp.2009.12.014.
47. Malatynska E et al. Anhedonic-like traits and lack of affective deficits in 18-month-old C57BL/6 mice: Implications for modeling elderly depression. Exp Gerontol. 2012;47(8):552-64.
48. Strekalova T, Steinbusch HW. Measuring behavior in mice with chronic stress depression paradigm. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(2):348-61.
49. Cryan JF, Valentino RJ, Lucki I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev. 2005;29(4-5):547-69.
50. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29(9):e45.
51. Marwah A, Marwah P, Lardy H. High-performance liquid chromatographic analysis of dehydroepiandrosterone. J Chromatogr A. 2001;935(1-2):279-96.
52. Dunn AJ, Swiergiel AH. Effects of interleukin-1 and endotoxin in the forced swim and tail suspension tests in mice. Pharmacol Biochem Behav. 2005;81(3):688-93.
53. Cryan JF, Mombereau C, Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev. 2005;29(4-5):571-625.
54. Koolhaas JM et al. The resident-intruder paradigm: a standardized test for aggression, violence and social stress. J Vis Exp. 2013;77:e4367.
55. Propes MJ, Johnson RW. Role of corticosterone in the behavioral effects of central interleukin-1 beta. Physiol Behav. 1997;61(1):7-13.
56. Cunningham C et al. Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biol Psychiatry. 2009;65(4):304-12.
57. Goto T et al. Subchronic and mild social defeat stress accelerates food intake and body weight gain with polydipsia-like features in mice. Behav Brain Res. 2014;270:339-48.
58. Quan N et al. Social stress increases the susceptibility to endotoxic shock. J Neuroimmunol. 2001;115(1-2):36-45.
59. Johnson JD et al. Prior stressor exposure sensitizes LPS-induced cytokine production. Brain Behav Immun. 2002;16(4):461-76.
60. Johnson JD et al. Effects of prior stress on LPS-induced cytokine and sickness responses. Am J Physiol Regul Integr Comp Physiol. 2003;284(2):R422-32.
61. Cohn DW, Kinoshita D, Palermo-Neto J. Antidepressants prevent hierarchy destabilization induced by lipopolysaccharide administration in mice: a neurobiological approach to depression. Ann N Y Acad Sci. 2012;1262:67-73.
62. Santiago RM et al. Antidepressant-like effect of celecoxib piroxicam in rat models of depression. J Neural Transm (Vienna). 2014;121(6):671-82.
63. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology. 2005;52(2):90-110.
64. Filipenko ML et al. Repeated experience of social defeats increases serotonin transporter and monoamine oxidase A mRNA levels in raphe nuclei of male mice. Neurosci Lett. 2002;321(1-2):25-8.
65. Kerman IA et al. High novelty-seeking predicts aggression and gene expression differences within defined serotonergic cell groups. Brain Res. 2011;1419:34-45.
66. Araragi N, Lesch KP. Serotonin (5-HT) in the regulation of depression-related emotionality: insight from 5-HT transporter and tryptophan hydroxylase-2 knockout mouse models. Curr Drug Targets. 2013;14(5):549-70.
67. Calabrese F et al. Exposure to early life stress regulates Bdnf expression in SERT mutant rats in an anatomically selective fashion. J Neurochem. 2015;132(1):146-54.
68. Baganz NL, Blakely RD. A dialogue between the immune system and brain, spoken in the language of serotonin. ACS Chem Neurosci. 2013;4(1):48-63.
69. Kalueff AV et al. Conserved role for the serotonin transporter gene in rat and mouse neurobehavioral endophenotypes. Neurosci Biobehav Rev. 2010;34(3):373-86.
70. Macchi F et al. Altered inflammatory responsiveness in serotonin transporter mutant rats. J Neuroinflammation. 2013;10:116.
71. Lotrich FE et al. Risk for depression during interferon-alpha treatment is affected by the serotonin transporter polymorphism. Biol Psychiatry. 2009;65(4):344-8.
72. Couch Y et al. Systemic inflammation alters central 5-HT function as determined by pharmacological MRI. Neuroimage. 2013;75:177-86.
73. Soloff PH et al. Effects of serotonin-2A receptor binding and gender on personality traits and suicidal behavior in borderline personality disorder. Psychiatry Res. 2014;222(3):140-8.
74. Savignac HM, et al. Prebiotic administration normalizes lipopolysaccharide (LPS)-induced anxiety and cortical 5-HT2A receptor and IL1-beta levels in male mice. Brain Behav Immun. 2016;52:120-31. doi: 10.1016/j.bbi.2015.10.007
75. Coppen A et al. Dexamethasone suppression test in depression and other psychiatric illness. Br J Psychiatry. 1983;142:498-504.
76. Kiecolt-Glaser JK, et al. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci U S A. 2003;100(15):9090-5.
77. Keller SE et al. Stress-induced suppression of immunity in adrenalectomized rats. Science. 1983;221(4617):1301-4.